These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6141615)

  • 1. Lack of cholinergic deficit in the neocortex in Pick's disease.
    Wood PL; Nair NP; Etienne P; Lal S; Gauthier S; Robitaille Y; Bird ED; Palo J; Haltia M; Paetau A
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):725-7. PubMed ID: 6141615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
    Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
    J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neocortical cholinergic neurons in elderly people.
    White P; Hiley CR; Goodhardt MJ; Carrasco LH; Keet JP; Williams IE; Bowen DM
    Lancet; 1977 Mar; 1(8013):668-71. PubMed ID: 66473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute subcortical lesions modify cortical muscarinic receptors in human brain.
    Bracco L; Corradetti R; Amaducci L
    Neurosci Lett; 1982 Dec; 34(3):227-31. PubMed ID: 7162704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Halonen T; Laakso M
    Life Sci; 1987 Jul; 41(4):453-61. PubMed ID: 3600187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subcortico-cortical cholinergic system is affected in Parkinson's disease.
    Dubois B; Ruberg M; Javoy-Agid F; Ploska A; Agid Y
    Brain Res; 1983 Dec; 288(1-2):213-8. PubMed ID: 6661617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical observations in a case of Pick's disease.
    Yates CM; Simpson J; Maloney AF; Gordon A
    J Neurol Sci; 1980 Nov; 48(2):257-63. PubMed ID: 7431041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M; Ploska A; Javoy-Agid F; Agid Y
    Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO; Lönnberg P; Marjamäki P; Rinne UK
    Brain Res; 1989 Apr; 483(2):402-6. PubMed ID: 2706531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K; Iseki E; Uchiyama H; Watanabe Y; Haga T; Kameyama K; Ikeda T; Yamamoto T; Kosaka K
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):209-13. PubMed ID: 10406992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.
    Bowen DM; Benton JS; Spillane JA; Smith CC; Allen SJ
    J Neurol Sci; 1982 Dec; 57(2-3):191-202. PubMed ID: 7161618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered serotonergic and cholinergic synaptic markers in Pick's disease.
    Sparks DL; Markesbery WR
    Arch Neurol; 1991 Aug; 48(8):796-9. PubMed ID: 1898253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
    Wilcock GK; Esiri MM; Bowen DM; Smith CC
    J Neurol Sci; 1982 Dec; 57(2-3):407-17. PubMed ID: 7161627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocortical morphometry and cholinergic neurochemistry in Pick's disease.
    Hansen LA; Deteresa R; Tobias H; Alford M; Terry RD
    Am J Pathol; 1988 Jun; 131(3):507-18. PubMed ID: 3381880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies.
    Odawara T; Shiozaki K; Iseki E; Hino H; Kosaka K
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):965-7. PubMed ID: 12810794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding.
    Morin AM; Wasterlain CG
    Neurochem Res; 1980 Mar; 5(3):301-8. PubMed ID: 7374884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.
    Mash DC; Flynn DD; Potter LT
    Science; 1985 May; 228(4703):1115-7. PubMed ID: 3992249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
    Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.